Andreas Kogelnik, MD, PhD, is the Director of the Institute. He completed his MD at Emory University School of Medicine and his PhD in Bioengineering at Georgia Tech. He trained as a resident in Internal Medicine and fellow in Infectious Diseases at Stanford University and remained there as a post-doc and research faculty before founding the Clinic in 2009 and Institute in 2011.
@wigglethemouse - Interesting because I thought Kogelnik split with Kaufman/Chheda at the same time this trial began because of divided focus on a clinical trial vs. patient treatment. Anyone know more?